3 Results for "

NADH and IFN

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "NADH and IFN" in MCE Product Catalog:

6
6 Cited Publications
Referencia número: HY-147124
No. CAS: 2642218-43-5
Pureza:  98.21%
Target:  

IFNAR

Áreas de investigación:  

Infection Cancer

RIG012 is a potent RIG-I inhibitor with an IC50 of 0.71 μM using the NADH-coupled ATPase assay. RIG012 inhibits IFN-β and ISG hRsad2 expression .
loading...
    loading...
Referencia número: HY-147124R
No. CAS: 2642218-43-5
Áreas de investigación:  

Inflammation/Immunology Cancer

RIG012 (Standard) is the analytical standard of RIG012 (HY-147124). This product is intended for research and analytical applications. RIG012 is a potent RIG-I inhibitor with an IC50 of 0.71 μM using the NADH-coupled ATPase assay. RIG012 inhibits IFN-β and ISG hRsad2 expression .
loading...
    loading...
Referencia número: HY-164628
No. CAS: 314039-40-2
Target:  

CD38

Áreas de investigación:  

Cancer

CD38-IN-5 (compound 1) is a CD38 inhibitor that selectively inhibits CD38 hydrolase with an IC50 of 4.0 μM. CD38-IN-5 does not inhibits CD38 cyclase. CD38-IN-5 is highly effective at promoting NK cell-mediated tumor toxicity. CD38-IN-5 increases NADH+ and IFNγ levels in activated PBMCs. CD38-IN-5 can be used for the study of cancer .
loading...
    loading...